Pathogenetic substantiation of using selenium-containing drugs for the correct disorders of the blood plasma fibrinolytic system in patients with chronic diffuse liver diseases and euthyroid syndrome pathology

Abstract

The dynamics of the indices of fibrinolysis and cellular adhesion in patients with chronic diffuse liver diseases and euthyroid syndrome against the ground of administration of selenium-containing drugs, has been studied. The administration of selenium-containing drugs in a comprehensive therapy of patients with chronic diffuse liver diseases with disorders of thyroid homeostasis was found to improve the indices of the blood plasma fibrinolytic system, to reduce adhesive cellular properties and to increase total enzymatic activity of the blood plasma.

Keywords

• chronic diffuse liver diseases
• disorders of thyroid homeostasis
• cellular adhesion
• fibrinolysis
• selenium